Market Overview

Moving Mountains for Multiple Myeloma to Hike Through Iceland

Share:

This hike marks the fifth continent to be visited by a Moving
Mountains for Multiple Myeloma team

As a part of a fundraising effort by Moving Mountains for Multiple
Myeloma (MM4MM), 15 individuals will take on a challenging hike through
Iceland from Aug. 8 to 12. MM4MM is a joint initiative between the
Multiple Myeloma Research Foundation, CURE Media Group and Celgene. The
upcoming climb includes patients, caregivers, team members from the
organizing partners and a myeloma doctor.

"As a patient founded organization, the MMRF stands together with those
who are battling multiple myeloma – patients, families, physicians,
researchers, and our pharmaceutical partners. This team represents a
microcosm of that myeloma community and demonstrates that together, we
can collaborate with ever increasing momentum towards a cure", said Paul
Giusti, CEO of the Multiple Myeloma Research Foundation. "We are
thrilled to enter the third year of this inspiring program and to have
Celgene join us in this effort to raise awareness and critical funds to
continue our mission." Called Fire and Ice, the hike will take the
participants through geologic marvels including volcanoes, glaciers,
geysers, hot springs, waterfalls and mountains. The proceeds will
benefit the foundation's life-changing efforts to further the
development of multiple myeloma treatments. The organization has raised
more than $2 million through six completed expeditions."

The team includes five individuals who are living with multiple myeloma:

  • Jen Phlieger Ansier, 31, of Austin, Texas, received a
    diagnosis of multiple myeloma after her general physician found
    unusual lab results during a routine physical. Soon after, she started
    therapy and then received an autologous stem cell transplant in
    February 2007. A second transplant was needed in 2011. Since then, she
    has been in remission. Though she does not consider herself an
    endurance athlete, Ansier said, she is excited to challenge herself
    with the strenuous hike and hopes to inspire other young patients who
    are battling myeloma.
  • Rich Appelbaum, 64, of Oceanside, New York, received his
    diagnosis of multiple myeloma in 2016. He believes that his years as a
    competitive wrestler more than 40 years ago prepared him for this
    diagnosis and this hike. Keeping the wrestling mantra "Never, ever
    quit!" in mind, Applebaum said, he is ready to take on this challenge
  • Barbara, McCarrick, 59, of Pleasanton, California,
    received her diagnosis in 2009. She responded well to treatment that
    included tandem stem cell transplants but relapsed in 2013. She is now
    in remission and said she is eager to take on Fire and Ice to benefit
    the Multiple Myeloma Research Foundation. "With research, clinical
    trials and new treatments, I will, hopefully, have a long remission
    and soon, a cure," she said.
  • Brian Smith, 35, of Bremerton, Washington,
    experienced severe neck and back pain in 2016. After X-rays and other
    tests revealed myeloma, Smith underwent a stem cell transplant and is
    now in remission. "I have refused to let this disease define me," he
    said. "I have worked hard to live my life as normally as I can and
    continue to do the things that I love." Trekking the mountains and
    valleys of Iceland is in line with this philosophy, he said.
  • Emily Schottman, 48, of Austin, a mother of two,
    learned in 2010 that she had multiple myeloma. Following a stem cell
    transplant and treatment, she has been in remission for 7 years.
    Shortly after she received her diagnosis, her family decided to live
    boldly and create experiences together, and they have traveled to 10
    countries since. Like others on the team, Schottman said she
    believes that this trek provides living proof that patients with
    myeloma are able to live their dreams.

"We are honored to be a part of this ongoing initiative," said Michael
J. Hennessy Jr., president of MJH Associates, Inc., parent company of
CURE Media Group. "These initiatives have not only played a crucial role
in raising funds and awareness but have also raised a sense of hope and
optimism among patients, caregivers and doctors."

"Celgene and the MMRF share an unyielding commitment to improving the
lives of patients with multiple myeloma and we are extremely honored to
participate in the Moving Mountains for Multiple Myeloma initiative,"
said Joel Beetsch, Ph.D., Vice President, Global Patient Advocacy for
Celgene. "The progress that has been made over the last decade in this
disease is remarkable, however, we recognize that there is work yet to
do, and are inspired by the participants in this unique program, which
is raising awareness and vital funds for multiple myeloma research."

To learn more about MM4MM and donate to multiple myeloma research,
please visit http://www.movingmountainsformultiplemyeloma.com/iceland18.

About Moving Mountains for Multiple Myeloma

Moving Mountains for Multiple Myeloma (MM4MM) is a collaboration between
CURE Media Group and the Multiple Myeloma Research Foundation to raise
awareness and funds for myeloma research. This year, Amgen and Celgene
Corporation join the effort as sponsors. In addition to Fire and Ice and
an earlier Havasu Falls, Arizona, trek, the program will do another trek
in 2018: In October, an Amgen-sponsored team will take on Everest Base
Camp. To date, MM4MM has raised over $2.0 million for myeloma research
and included 34 myeloma patients on 7 climbs. Funds raised go directly
to research, supporting the MMRF mission. For more information, visit https://www.themmrf.org/events/.

About Multiple Myeloma

Multiple myeloma, a cancer of the plasma cell, is the second most common
blood cancer. An estimated 30,000 adults will be diagnosed this year,
and 12,600 people are predicted to die from the disease.

About the Multiple Myeloma Research Foundation

The mission of the Multiple Myeloma Research Foundation (MMRF) is to
find a cure for multiple myeloma by relentlessly pursuing innovation
that accelerates the development of next-generation treatments to extend
patients' lives. Founded in 1998 as a 501(c)(3) nonprofit organization
by Kathy Giusti, a patient with multiple myeloma, and her twin sister,
Karen Andrews, the MMRF is a world-recognized leader in cancer research.
Together with its partners, the MMRF created the only end-to-end
solution in precision medicine and the single largest genomic data set
in all cancers. As a pioneer and leader at the helm of new research
efforts, the MMRF continues to disrupt the industry. Since its
inception, the organization has raised more than $400 million and
directs nearly 90 percent of the total funds to research and related
programs. To learn more, visit www.themmrf.org.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research
and education. It combines a full suite of media products, including its
industry-leading website, CUREtoday.com; innovative video programs, such
as CURE Connections®; a series of widely attended live events; and CURE®
magazine, which reaches over 1 million readers. CURE Media Group is part
of the Cranbury, New Jersey-based MJH Associates Inc. family of
businesses, which includes the acclaimed OncLive® (http://www.onclive.com)
platform of resources for the practicing oncologist. For more
information, visit http://www.curetoday.com or http://www.mjhassoc.com

View Comments and Join the Discussion!